Acute pharmacologic blockade of dyskinesias in Parkinson's disease

Mov Disord. 1996 Sep;11(5):580-1. doi: 10.1002/mds.870110516.

Authors

P J Blanchet¹, L V Metman, M M Mouradian, T N Chase

Affiliation

¹ Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke Bethesda, Maryland, USA.

PMID: 8866502
DOI: 10.1002/mds.870110516

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Dextrorphan / administration & dosage
Dextrorphan / therapeutic use*
Double-Blind Method
Drug Therapy, Combination
Excitatory Amino Acid Antagonists / administration & dosage
Excitatory Amino Acid Antagonists / therapeutic use*
Humans
Levodopa / therapeutic use
Middle Aged
Movement Disorders / complications*
Movement Disorders / drug therapy*
Parkinson Disease / complications*
Placebos
Severity of Illness Index

Substances

Excitatory Amino Acid Antagonists
Placebos
Dextrorphan
Levodopa